These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 8553544

  • 1. Genetic determinants of feline leukemia virus-induced multicentric lymphomas.
    Athas GB, Choi B, Prabhu S, Lobelle-Rich PA, Levy LS.
    Virology; 1995 Dec 20; 214(2):431-8. PubMed ID: 8553544
    [Abstract] [Full Text] [Related]

  • 2. Coincident involvement of flvi-2, c-myc, and novel env genes in natural and experimental lymphosarcomas induced by feline leukemia virus.
    Levy LS, Lobelle-Rich PA, Overbaugh J, Abkowitz JL, Fulton R, Roy-Burman P.
    Virology; 1993 Oct 20; 196(2):892-5. PubMed ID: 8396818
    [Abstract] [Full Text] [Related]

  • 3. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement.
    Tsatsanis C, Fulton R, Nishigaki K, Tsujimoto H, Levy L, Terry A, Spandidos D, Onions D, Neil JC.
    J Virol; 1994 Dec 20; 68(12):8296-303. PubMed ID: 7966623
    [Abstract] [Full Text] [Related]

  • 4. Cooperating events in lymphomagenesis mediated by feline leukemia virus.
    Levy LS, Starkey CR, Prabhu S, Lobelle-Rich PA.
    Leukemia; 1997 Apr 20; 11 Suppl 3():239-41. PubMed ID: 9209353
    [Abstract] [Full Text] [Related]

  • 5. Feline leukemia virus variants in experimentally induced thymic lymphosarcomas.
    Pandey R, Bechtel MK, Su Y, Ghosh AK, Hayes KA, Mathes LE, Roy-Burman P.
    Virology; 1995 Dec 20; 214(2):584-92. PubMed ID: 8553560
    [Abstract] [Full Text] [Related]

  • 6. The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication.
    Prabhu S, Lobelle-Rich PA, Levy LS.
    Virology; 1999 Oct 25; 263(2):460-70. PubMed ID: 10544118
    [Abstract] [Full Text] [Related]

  • 7. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A.
    Boomer S, Gasper P, Whalen LR, Overbaugh J.
    Virology; 1994 Nov 01; 204(2):805-10. PubMed ID: 7941350
    [Abstract] [Full Text] [Related]

  • 8. Molecular pathogenesis of feline leukemia virus-induced malignancies: insertional mutagenesis.
    Fujino Y, Ohno K, Tsujimoto H.
    Vet Immunol Immunopathol; 2008 May 15; 123(1-2):138-43. PubMed ID: 18313764
    [Abstract] [Full Text] [Related]

  • 9. The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.
    Bolin LL, Ahmad S, Lobelle-Rich PA, Ooms TG, Alvarez-Hernandez X, Didier PJ, Levy LS.
    J Virol; 2013 Oct 15; 87(19):10874-83. PubMed ID: 23903838
    [Abstract] [Full Text] [Related]

  • 10. Identification of a novel common proviral integration site, flit-1, in feline leukemia virus induced thymic lymphoma.
    Fujino Y, Liao CP, Zhao YS, Pan J, Mathes LE, Hayes KA, Ohno K, Tsujimoto H, Roy-Burman P.
    Virology; 2009 Mar 30; 386(1):16-22. PubMed ID: 19203775
    [Abstract] [Full Text] [Related]

  • 11. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
    Johnson C, Lobelle-Rich PA, Puetter A, Levy LS.
    J Virol; 2005 Jan 30; 79(1):57-66. PubMed ID: 15596801
    [Abstract] [Full Text] [Related]

  • 12. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y, Morimoto M, Katsumata M, Uchida A, Aozasa K, Okamoto M, Kurosawa T, Ochi T, Greene MI, Tsujimoto Y.
    Oncogene; 1995 Nov 02; 11(9):1729-36. PubMed ID: 7478600
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors.
    Terry A, Fulton R, Stewart M, Onions DE, Neil JC.
    J Virol; 1992 Jun 02; 66(6):3538-49. PubMed ID: 1316466
    [Abstract] [Full Text] [Related]

  • 14. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
    Chandhasin C, Coan PN, Levy LS.
    J Virol; 2005 Feb 02; 79(3):1351-60. PubMed ID: 15650161
    [Abstract] [Full Text] [Related]

  • 15. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays.
    Tandon R, Cattori V, Willi B, Lutz H, Hofmann-Lehmann R.
    Vet Immunol Immunopathol; 2008 May 15; 123(1-2):129-33. PubMed ID: 18295344
    [Abstract] [Full Text] [Related]

  • 16. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.
    Chandhasin C, Coan PN, Pandrea I, Grant CK, Lobelle-Rich PA, Puetter A, Levy LS.
    J Virol; 2005 May 15; 79(9):5278-87. PubMed ID: 15827142
    [Abstract] [Full Text] [Related]

  • 17. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma.
    Rohn JL, Lauring AS, Linenberger ML, Overbaugh J.
    J Virol; 1996 Nov 15; 70(11):8071-80. PubMed ID: 8892932
    [Abstract] [Full Text] [Related]

  • 18. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes.
    Rigby MA, Rojko JL, Stewart MA, Kociba GJ, Cheney CM, Rezanka LJ, Mathes LE, Hartke JR, Jarrett O, Neil JC.
    J Gen Virol; 1992 Nov 15; 73 ( Pt 11)():2839-47. PubMed ID: 1331290
    [Abstract] [Full Text] [Related]

  • 19. Advances in understanding molecular determinants in FeLV pathology.
    Levy LS.
    Vet Immunol Immunopathol; 2008 May 15; 123(1-2):14-22. PubMed ID: 18289704
    [Abstract] [Full Text] [Related]

  • 20. Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats.
    Ellis JA, Jackson ML, Bartsch RC, McGill LG, Martin KM, Trask BR, Haines DM.
    J Am Vet Med Assoc; 1996 Aug 15; 209(4):767-71. PubMed ID: 8756876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.